New Stock News | New Element Pharmaceutical Company Plans to List on the Hong Kong Stock Exchange. The China Securities Regulatory Commission requires supplementary explanations on the basic information of new shareholders added in the last 12 months, among other matters.

According to the Securities Times app, on October 31st, the China Securities Regulatory Commission announced the "Supplementary Materials Requirements for Overseas Issuance and Listing Record (October 27, 2025 - October 31, 2025)". The International Department of the China Securities Regulatory Commission issued supplementary material requirements to 9 companies, including a requirement for Xinyuan Pharmaceutical to supplement information on the basic situation of new shareholders added in the past 12 months. It is reported that Xinyuan Pharmaceutical submitted its listing application to the main board of the Hong Kong Stock Exchange on September 15, 2025, with CITIC Securities as its exclusive sponsor.